Fintel reports that on April 21, 2025, Wolfe Research upgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) from ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room for improvement. A new ...

Farmers could soon start testing the effectiveness of gene-edited technology to control Spotted Winged Drosophila with ...

Taking note of this, Pia and his colleagues used the CRISPR-Cas9 technology, which targets SOX2. CRISPR-Cas9 is like a pair of scissors that can cut specific genes in DNA and is known to be able ...

ToolGen files patent infringement lawsuit against Vertex Pharma in UK for genome editing therapy CASGEVY: Seoul, South Korea Tuesday, April 22, 2025, 15:00 Hrs [IST] ToolGen, Inc.

As the demand for precision and efficiency in genetic research continues to grow, Creative Biogene's CRISPR library screening service stands out, allowing scientists to quickly identify and analyze ...

ERS Genomics provides essential and foundational licenses to its Nobel prize winning CRISPR/Cas9 technology to companies integrating it into their commercial programs. With a portfolio of 100 ...

John E. Milad, CEO, ERS Genomics, commented: "We are pleased to support Jumpcode Genomics in their mission to enhance next-generation sequencing through CRISPR technology. By leveraging our ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

CASGEVY became the world's first genome editing therapy to receive marketing authorization, beginning with the United Kingdom ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.